Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Diabetes

Free Subscription Articles published in Am J Nephrol Retrieve available abstracts of 28 articles: HTML format

Single Articles

May 2024
1. MOLONEY BM, Chertow GM, Mc Causland FR
   Association of Diabetes with Changes in Blood Pressure during Hemodialysis: A Secondary Analysis of the Frequent Hemodialysis Network Daily Trial.
   Am J Nephrol. 2024 May 23. doi: 10.1159/000539451.
   PubMed     Abstract available
   
   
   February 2024
2. STAVAS J, Silva AL, Wooldridge TD, Aqeel A, et al
   Rilparencel (Renal Autologous Cell Therapy-REACT(R)) for Chronic Kidney Disease and Type 1 and 2 Diabetes: Phase 2 Trial Design Evaluating Bilateral Kidney Dosing and Re-Dosing Triggers.
   Am J Nephrol. 2024 Feb 29. doi: 10.1159/000537942.
   PubMed     Abstract available
   
   
   
3. MAKAWI AT, Tawfik YMK, Dixon DL, McMahon GM, et al
   Expanding the Impact of SGLT2 Inhibitors in Chronic Kidney Disease.
   Am J Nephrol. 2024 Feb 28:1-4. doi: 10.1159/000536540.
   PubMed    
   
   
   
4. CROUCH E, Yell N, Herbert L, Browne T, et al
   Availability and quality of dialysis care in rural versus urban U.S. counties.
   Am J Nephrol. 2024 Feb 11. doi: 10.1159/000537763.
   PubMed     Abstract available
   
   
   January 2024
5. TUTTLE KR, Rossing P, Hauske SJ, Cronin L, et al
   Methods Article for a Study Protocol: Study Design and Baseline Characteristics for Aldosterone Synthase Inhibition in Chronic Kidney Disease.
   Am J Nephrol. 2024;55:262-272.
   PubMed     Abstract available
   
   
   November 2023
6. GAO LQ, Xue CC, Cui J, Xu J, et al
   Diabetic Retinopathy and Chronic Kidney Disease: Associations and Comorbidities in a Large Diabetic Population: The Tongren Health Care Study.
   Am J Nephrol. 2023 Nov 10. doi: 10.1159/000535059.
   PubMed     Abstract available
   
   
   October 2023
7. CHUANG GT, Kremer D, Huang CH, Alkaff FF, et al
   Urinary Fetuin-A Fragments Predict Progressive eGFR Decline in Two Independent Type 2 Diabetes Cohorts of Different Ethnicities.
   Am J Nephrol. 2023 Oct 9. doi: 10.1159/000534514.
   PubMed     Abstract available
   
   
   
8. TSAI HL, Lin TC, Lin NC, Yang HH, et al
   Risk factors for fractures in renal transplantation: a population-based cohort study.
   Am J Nephrol. 2023 Oct 2. doi: 10.1159/000533125.
   PubMed     Abstract available
   
   
   September 2023
9. CHINNADURAI R, Rengarajan S, Budden JJ, Quinn CM, et al
   Maintaining renin-angiotensin-aldosterone system inhibitor treatment with patiromer in hyperkalaemic chronic kidney disease patients: comparison of a propensity-matched real-world population with AMETHYST-DN.
   Am J Nephrol. 2023 Sep 19. doi: 10.1159/000533753.
   PubMed     Abstract available
   
   
   
10. KOYA D, Anker SD, Ruilope LM, Rossing P, et al
    Cardiorenal Outcomes with Finerenone in Asian Patients with Chronic Kidney Disease and Type 2 Diabetes: A FIDELIO-DKD post hoc Analysis.
    Am J Nephrol. 2023 Sep 14:1-9. doi: 10.1159/000532102.
    PubMed     Abstract available
    
    
    July 2023
11. YANG WS, Chuang GT, Che TP, Chueh LY, et al
    Genome-Wide Association Studies for Albuminuria of non-Diabetic Taiwanese Population.
    Am J Nephrol. 2023 Jul 12. doi: 10.1159/000531783.
    PubMed     Abstract available
    
    
    May 2023
12. LI X, Qureshi AR, Suliman ME, Heimburger O, et al
    Interleukin-6 to albumin ratio as a superior predictor of mortality in end stage kidney disease patients.
    Am J Nephrol. 2023 May 24. doi: 10.1159/000531191.
    PubMed     Abstract available
    
    
    
13. XIAO Y, Xiao Z
    Association between serum Klotho and kidney stones in US middle-aged and older individuals with diabetes mellitus: Results from 2007-2016 National Health and Nutrition Survey.
    Am J Nephrol. 2023 May 15:1. doi: 10.1159/000531045.
    PubMed     Abstract available
    
    
    March 2023
14. SINGH AP, Kalil R, Weir MR
    Role of Sodium-Glucose Cotransporter 2 inhibitors for management of diabetes mellitus in renal transplant recipients; and management strategies for post-transplant hypertension.
    Am J Nephrol. 2023 Mar 24. doi: 10.1159/000530296.
    PubMed     Abstract available
    
    
    
15. RIZK JG, Hsiung JT, Arif Y, Hashemi L, et al
    Triglycerides and Renal Outcomes according to Albuminuria and in Consideration of other Metabolic Syndrome Components in Diabetic US Veterans.
    Am J Nephrol. 2023 Mar 8. doi: 10.1159/000529414.
    PubMed     Abstract available
    
    
    February 2023
16. TUTTLE KR, Wilson JM, Lin Y, Qian HR, et al
    Indicators of Kidney Fibrosis in Patients With Type 2 Diabetes and Chronic Kidney Disease Treated With Dulaglutide.
    Am J Nephrol. 2023 Feb 8. doi: 10.1159/000529374.
    PubMed     Abstract available
    
    
    January 2023
17. MENDE CW, Samarakoon R, Higgins PJ
    [Mineralocorticoid receptor (MR)-associated mechanisms in diabetic kidney disease and clinical significance of MR antagonists].
    Am J Nephrol. 2023 Jan 20. doi: 10.1159/000528783.
    PubMed     Abstract available
    
    
    
18. CHEN TK, Coca SG, Thiessen-Philbrook HR, Heerspink HJL, et al
    [Urinary Biomarkers of Tubular Health and Risk for Kidney Function Decline or Mortality in Diabetes].
    Am J Nephrol. 2023 Jan 11. doi: 10.1159/000528918.
    PubMed     Abstract available
    
    
    December 2022
19. CHIU V, Gross AL, Chu NM, Segev D, et al
    Domains for a Comprehensive Geriatric Assessment of Older Adults with Chronic Kidney Disease: Results from the CRIC Study.
    Am J Nephrol. 2022 Dec 9. doi: 10.1159/000528602.
    PubMed     Abstract available
    
    
    September 2022
20. GRUPPER A, Rabinowich A, Ben Shabat I, Tzadok R, et al
    Nonalcoholic Fatty Liver Disease before Kidney Transplantation Correlates with New Onset Diabetes and Poor Metabolic Outcomes.
    Am J Nephrol. 2022 Sep 8:1-10. doi: 10.1159/000526118.
    PubMed     Abstract available
    
    
    June 2022
21. THEOFILIS P, Vordoni A, Kalaitzidis RG
    The Role of Melatonin in Chronic Kidney Disease and Its Associated Risk Factors: A New Tool in Our Arsenal?
    Am J Nephrol. 2022 Jun 29:1-10. doi: 10.1159/000525441.
    PubMed     Abstract available
    
    
    February 2022
22. ZHANG J, Fuhrer T, Ye H, Kwan B, et al
    High-Throughput Metabolomics and Diabetic Kidney Disease Progression: Evidence from the Chronic Renal Insufficiency (CRIC) Study.
    Am J Nephrol. 2022 Feb 23:1-11. doi: 10.1159/000521940.
    PubMed     Abstract available
    
    
    January 2022
23. STAVAS J, Gerber D, Coca SG, Silva AL, et al
    Novel Renal Autologous Cell Therapy for Type 2 Diabetes Mellitus Chronic Diabetic Kidney Disease: Clinical Trial Design.
    Am J Nephrol. 2022 Jan 14:1-9. doi: 10.1159/000520231.
    PubMed     Abstract available
    
    
    
24. LAM D, Nadkarni GN, Mosoyan G, Neal B, et al
    Clinical Utility of KidneyIntelX in Early Stages of Diabetic Kidney Disease in the CANVAS Trial.
    Am J Nephrol. 2022 Jan 11:1-11. doi: 10.1159/000519920.
    PubMed     Abstract available
    
    
    
25. SUZUKI Y, Kaneko H, Okada A, Itoh H, et al
    Impact of Glucose Tolerance and Its Change on Incident Proteinuria: Analysis of a Nationwide Population-Based Dataset.
    Am J Nephrol. 2022;53:307-315.
    PubMed     Abstract available
    
    
    
26. CHERNEY DZI, Cosentino F, Dagogo-Jack S, McGuire DK, et al
    Initial eGFR Changes with Ertugliflozin and Associations with Clinical Parameters: Analyses from the VERTIS CV Trial.
    Am J Nephrol. 2022;53:516-525.
    PubMed     Abstract available
    
    
    December 2021
27. FERREIRA JP, Rossignol P, Bakris G, Mehta C, et al
    Blood and Urine Biomarkers Predicting Worsening Kidney Function in Patients with Type 2 Diabetes Post-Acute Coronary Syndrome: An Analysis from the EXAMINE Trial.
    Am J Nephrol. 2021 Dec 6:1-8. doi: 10.1159/000519436.
    PubMed     Abstract available
    
    
    March 2021
28. CHO ME, Sweeney C, Fino N, Greene T, et al
    Longitudinal Changes in Prorenin and Renin in the Chronic Renal Insufficiency Cohort.
    Am J Nephrol. 2021 Mar 18:1-11. doi: 10.1159/000514302.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.